Lipodystrophies are rare, heterogeneous, genetic or acquired, disorders characterised by
varying degrees of body fat loss and associated metabolic complications, including insulin
resistance, dyslipidaemias, hepatic steatosis and predisposition to atherosclerotic
cardiovascular disease (ASCVD). The four main types of lipodystrophy, excluding
antiretroviral therapy-induced lipodystrophy in HIV-infected patients, are congenital
generalised lipodystrophy (CGL), familial partial lipodystrophy (FPLD), acquired generalised …